An American woman’s comparison of medicine prices in the United States and India has gone viral on social media, reigniting a global debate over healthcare affordability. In a widely shared Instagram video, the woman claimed that a cancer medication costing around $900 (approximately ₹85,000) per pill in the United States is available in India for as little as ₹35 in its generic form.
The striking price difference has prompted thousands of reactions online, with many users praising India’s generic pharmaceutical industry while criticizing the high cost of healthcare in the United States.
Viral Video Highlights Massive Price Gap
The woman, identified as Liz, shared the video under the title “Indian vs American Healthcare.” She explained that her aunt is undergoing treatment for a form of blood cancer and requires a medicine known as Revlimid, a branded version of the drug lenalidomide.
According to Liz, a single pill of the branded medicine costs nearly $900 in the US. However, after checking prices in India, she found that generic versions of the same medicine are available for anywhere between ₹35 and ₹300 per tablet.
Expressing disbelief, she remarked that Americans were “being robbed” while highlighting India’s affordable access to medicines.
Why Is There Such a Huge Difference?
The viral discussion has drawn attention to the significant differences between pharmaceutical pricing systems in the two countries.
Several factors contribute to India’s lower medicine prices:
- A strong generic drug manufacturing industry
- Government price regulation on essential medicines
- High domestic competition among pharmaceutical companies
- Lower production and distribution costs
- Availability of affordable generic alternatives after patent limitations
In contrast, branded medicines in the United States often carry substantially higher prices due to patent protections, insurance structures, research and development costs, and market dynamics.
India’s Generic Medicine Industry Gains Recognition
India is widely regarded as one of the world’s largest producers of generic medicines and is often referred to as the “Pharmacy of the World.” The country supplies affordable medicines to more than 200 nations and plays a crucial role in making life-saving drugs accessible across developing countries.
Government initiatives promoting generic medicines have also helped reduce treatment costs for millions of patients.
Social Media Reacts
The video quickly attracted hundreds of thousands of views and sparked widespread discussion online.
Many users supported Liz’s observations, with comments highlighting the affordability of healthcare in India.
Some users wrote that cancer treatment and medicines are available at significantly lower costs in India, while others suggested that Americans could save money by purchasing eligible medicines during visits to India, subject to applicable laws and medical guidance.
Others criticized the high cost of prescription drugs in the US healthcare system, calling for reforms to improve affordability.
Similar Story Surfaced Earlier
This is not the first time an American has drawn attention to India’s low-cost medicines.
Earlier, another US resident named Victoria shared her experience of purchasing a medication from India for a fraction of its price after reportedly finding it unaffordable in the United States. Her video also went viral and renewed conversations about global drug pricing.
Experts Urge Caution While Comparing Prices
While the viral comparison has impressed many viewers, healthcare experts note that direct comparisons can be complex.
Medicine prices vary depending on:
- Brand versus generic versions
- Insurance coverage
- Patent status
- Country-specific regulations
- Manufacturer and dosage
Patients are advised to purchase prescription medicines only through licensed pharmacies and consult healthcare professionals before switching between branded and generic drugs.
A Growing Conversation on Global Healthcare
The viral video has once again highlighted the stark differences in healthcare costs around the world. For many social media users, India’s affordable generic medicines have become a symbol of accessible healthcare, while the discussion has also renewed scrutiny of rising prescription drug prices in developed nations.
As debates over healthcare affordability continue, the comparison has drawn fresh international attention to India’s role as a leading supplier of cost-effective medicines.
Key Highlights
- An American woman claimed a cancer medicine costing ₹85,000 per pill in the US is available in India for ₹35–₹300.
- The viral Instagram video has generated widespread discussion on global healthcare costs.
- India’s generic pharmaceutical industry continues to be recognized for producing affordable medicines.
- Experts say medicine prices differ due to patents, insurance systems, regulations, and branded versus generic products.
- The viral comparison has renewed debate over prescription drug pricing in the United States.
